Adequan® Legacy

A 30-year legacy of making a difference for horses and the equine industry

Since the beginning, Adequan® i.m. has been making a difference for all types of horses. We also have a long history of supporting the professionals, the owners and the countless people who share our dedication to the health and well-being of horses. In 2019, we celebrated our 30th anniversary and we are proud of the milestones we have experienced.


Adequan® i.m. becomes the first and only FDA-Approved equine PSGAG joint treatment for degenerative joint disease. It utilizes a unique disease-modifying molecule only found in Adequan. Luitpold Animal Health opens the only FDA-Approved PSGAG manufacturing site in the country to ensure consistent quality and purity.


Major study on efficacy of Adequan® i.m. published in The Journal of Equine Veterinary Science.


Began sponsorship of Horses in the Sun, National Reining Horse Association, United States Eventing Association, United States Equestrian Foundation.


Began sponsorship of American Association of Equine Practitioners, National Collegiate Equestrian Association, PATH International Convention and Veterinarian of the Year Award.


Began title sponsorship of Annual Convention and Awards, and National Championship for United States Dressage Federation.


Corporate partner for Arabian Horse Association, The International Society of Equine Locomotor Pathology and Gold Sponsorship of American Horse Council.


Corporate partner for American Quarter Horse Association and Sponsor of Jumping Grand Prix at Winter Equestrian Festival.


Begin sponsorship of Adequan Dressage Festival


Begin sponsorship of Live Oak International.


Launch Adequan Best Turned Out Award and Adequan Stables at the Breeder’s Cup. Major sponsor of Adequan Grand Prix and Facility at the Colorado Horse Park. Sponsor of Adequan Barn at the Ohio Quarter Horse Association Quarter Horse Congress Title sponsor for all CDI Dressage events, Adequan Grand Prix Jumping FEI summer and fall competitions as well as elite level sponsor at Tryon International Equestrian Center.


Title sponsor of the Adequan Stables at the World Equestrian Games and Discipline sponsor of the Para Dressage competition.


Luitpold Animal Health becomes American Regent Animal Health, a division of American Regent, Inc., manufacturer of Adequan®.


Celebrating 30 years of Adequan® i.m. as the only PSGAG equine joint prescription available. First of a kind. Still one of a kind.


Adequan® i.m. returns to Canada.

INDICATIONS Adequan® i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
IMPORTANT SAFETY INFORMATION There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For full prescribing information, click here.

Let’s stay in touch

Be the first to hear about important news and product information!
First, select the one that best describes you.
Then we'll take you to our sign-up page.

About Us Our Brands
Animal Health Logo